Mutations in the human FBN1 gene are known to be associated with the Marfan syndrome, an autosomal dominant inherited multi-systemic connective tissue disorder. However, in the absence of solid genotype-phenotype correlations, the identification of an FBN1 mutation has only little prognostic value. We propose a bioinformatics framework for the mutated FBN1 gene which comprises the collection, management, and analysis of mutation data identified by molecular genetic analysis (DHPLC) and data of the clinical phenotype. To query our database at different levels of information, a relational data model, describing mutational events at the cDNA and protein levels, and the diseaseÕs phenotypic expression from two alternative views, was implemented. For database similarity requests, a query model which uses a distance measure based on log-likelihood weights for each clinical manifestation, was introduced. A data mining strategy for discovering diagnostic markers, classification and clustering of phenotypic expressions was provided which enabled us to confirm some known and to identify some new genotype-phenotype correlations.
Introduction
FBN1 (OMIM #134797) is the gene known to be associated with the Marfan syndrome (MFS, OMIM #154700), an autosomal dominant inherited multi-systemic connective tissue disorder with prominent clinical manifestations in the cardiovascular, musculoskeletal, and ocular systems (OMIM: www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM). Its prevalence is 1/5000. In about 70% of MFS patients, mutations in the FBN1 gene could be detected [1] . The following categories of FBN1 mutations have been described: nucleotide substitutions (missense, nonsense, silent, and splicing mutations), insertions, deletions, indels, duplications, and complex rearrangements, some of which cause premature termination and exon skipping, respectively [2] [3] [4] .
The diagnosis of MFS is dependent on a catalogue of international diagnostic criteria summarized in the Gent nosology [5] . The major source of morbidity and early death in MFS relates to the cardiovascular system. Weakness of the aortic wall can lead to aortic dissection or rupture [6] . However, before life threatening complications occur, alterations of aortic elastic properties can be detected through the examination and monitoring of aortic elasticity during care follow-up [7] [8] [9] [10] .
Molecular genetic testing like mutation scanning or cDNA sequence analysis has been proposed as an adjunct to the clinical diagnosis of the MFS [5, 11, 12] . However, many mutations of FBN1 cause phenotypic expressions that are distinct from MFS, which rely on the age-related and pleiotropic nature of the disease [13] . Furthermore, only few genotype-phenotype correlations have been found in MFS [1, [13] [14] [15] [16] [17] . In the absence of solid genotype-phenotype correlations, the identification of an FBN1 mutation has only little prognostic value or consequence for the patientÕs diagnostic and therapeutic management.
In this work, we developed a bioinformatics framework to support genotype-phenotype correlations using a suite of statistical methods, algorithms and database applications: Core component is an FBN1 information system which collects, manages and analyzes genetic information as gained from molecular genetic testing and clinical data according to a standardized catalogue of diagnostic criteria. To query the database (DB) at different levels of genetic and phenotypic information, a relational data model was developed which models mutational events at the cDNA and protein levels, and MFS phenotypic expression from two alternative views. A query model was introduced which uses a distance measure based on log-likelihood weights for each clinical manifestation to query the DB for mutations of related phenotypic expressions. A straightforward data mining strategy for the identification of diagnostic markers, classification and cluster analysis of phenotypic expressions was provided to perform genotype-phenotype investigations. Initial experiments confirmed some known correlations and identified some novel ones when using the proposed framework.
Methods

Genotyping and phenotyping
FBN1 gene and fibrillin-1 protein
The FBN1 gene, located on chromosome 15q21.1, is about 236 kb in size and contains 65 exons. The gene is transcribed in a 9.7 kb mRNA which encodes a 2871 amino acids large fibrillin-1 glycoprotein (320 kDa). Fibrillin-1 is ubiquitously distributed in connective tissue and mainly made up of calcium-binding epidermal growth factor (cb-EGF)-like, EGF-like, and cysteine rich domains interacting with many extracellular matrix components. For general information on the FBN1 gene see: www.ncbi.nlm.nih.gov/entrez/ query.fcgi?db=gene, www.dsi.univ-paris5.fr/genatlas or www.umd.be:2030/Protein.html.
Mutation analysis of the FBN1 gene
Denaturing high-performance liquid chromatography (DHPLC) of all 65 FBN1 exons is available on a clinical basis. Genomic DNA samples were amplified exon by exon by means of a polymerase chain reaction (PCR) using intron-specific primers. Quality and quantity of PCR products were determined on 1.5% agarose gel by standard procedures. Amplicons were analyzed by DHPLC followed by direct sequencing of amplicons with abnormal elution profiles. The mutations found were verified by repeated sequencing on newly amplified PCR products. In the case of splice site mutations and when no mutation was detected by DHPLC, FBN1 transcripts were analyzed by the reverse transcription (RT)-PCR of RNA templates isolated from fibroblasts. RT-PCR amplifications and sequencing of transcripts were also performed by standard procedures [18] .
The clinical phenotype
Classic or suspected MFS is a clinical diagnosis based on family history and the observation of characteristic manifestations in multiple organ systems [5] . The management of data collection requires the coordinated input of a multidisciplinary team of specialists including cardiologists, ophthalmologists, orthopedists, and geneticists. Within our Innsbruck/Zurich FBN1-network, anonymized clinical, and genetic data (mutation scanning is performed by the Zurich group, University ChildrenÕs Hospital Zurich, Switzerland) are brought together at the Innsbruck Marfan Clinical Center, Clinical Division of Pediatric Cardiology, Innsbruck Medical University, ready for entering into the database.
The database
For our experiments, genetic and phenotypic data has been collected from different sources. The data were anonymously provided by the University ChildrenÕs Hospital of Zurich, Switzerland and Innsbruck Medical University, Austria [9] , and extended by data recently published [17, [19] [20] [21] [22] .
Our current research DB contains 163 entries with 127 different mutations (mean patientsÕ age 24.3 ± 15.4 years). The different numbers of entries and mutations arise from entries of 22 families (between two and six family members) carrying the same mutation. One hundred and nineteen entries are substitutions (Sub), 44 are distributed amongst deletions (Del), insertions (Ins), duplications (Dup), and indel mutations (Indel). The group of substitutions can be split into 78 missense (Mis), 27 nonsense (Stop), and 14 splice site mutations (Splice). Out of the pool of non-substitutions (Del, Ins, Dup, and Indel) 31 entries are deletions causing frameshift (FS) and premature termination codon (PTC).
We investigated 14 Gent criteria which were consistently described in the publications presenting clinical data: ocular system: 1. ectopia lentis (EL); cardiovascular system: 2. dilation of ascending aorta (AADIL), 3. dissection of ascending aorta (AADIS), 4. mitral valve prolapse (MVP); skeletal system: 5. pectus carinatum (PC), 6 . pectus excavatum requiring surgery (PES), 7. arm span ratio (ASR), 8. wrist or thumb sign (WTS), 9. scoliosis (SC), 10. moderate pectus excavatum (PE), 11. joint hypermobility (JH), 12. highly arched palate with crowding of teeth (HAP); skin system: 13. striae atrophicae (SA) and 14. herniae (HE). For a more detailed description see Fig. 1B. 
FBN1 information system
The information system, which is embedded in a J2EE three tier architecture consisting of client, application and data tier, provides cross-DBMS (database management system) connectivity to a relational DBMS using a modern server environment and JDBC technology. A genotype-phenotype data model was designed and implemented to query the database at different levels of genetic and phenotypic information (see next section). Modules for data collection, administration, and analysis are provided as web-based services, which are still under construction.
Genotype-phenotype data model
An international nomenclature system has been suggested for the description of mutations and polymorphisms in DNA and protein sequences [23] . Based on these recommendations, we designed a genotype data model which describes sequence variations at both cDNA and protein levels, systematically. Fig. 1A depicts the genotype data model represented by a simplified UML class diagram. The top compartment contains the name of the class (= DB relation), the bottom compartment the list of attributes declared as SQL data types. Associations between relations are modeled by 0.1 relationships. The description of nucleotide changes at the cDNA level was modeled by introducing class attributes according to the international mutation nomenclature. To define mutations, different sub-types of nucleotide changes were considered. The consequence of mutations at the protein level are described and modeled in a similar way. The genotype general description class represents the combination of mutation types at the DNA level and their consequence at the protein level, the affected exons/introns and protein domains. For representation issues three different mutations are exemplified in Table 1 .
The phenotype data model was designed according to the multi-systemic picture of the disease (Gent nosology). Fig. 1B depicts the UML class diagram of the clinical phenotype in more detail: Each affected organ system, i.e., the skeletal, cardiovascular (CVS), ocular, pulmonary, skin and integument, and dura system, was modeled from a more general view to emphasize the system involvement and the accumulated number of diagnosed criteria. To be more specific, each organ system was further separated into sub-systems which contain the single manifestations. A general patient information class provides additional information according to the patientÕs ethnics, sex, age, MFS type (e.g., classical, suspected), and family history. Nucleotide changes-DNA level Name 
Nucleotide changes at the cDNA level, amino acid (AA) changes at the protein level specified by their subtypes, and a general genotype description are exemplified for a substitution/missense mutation (Sub/Mis), a substitution/nonsense mutation (Sub/Stop) and a deletion causing FS + PTC (Del/ Fs). Attribute values are given in SQL data types. The Deletion-Prot class is not exemplified because it is only relevant for deleted units of at least one AA.
Similarity query processing
We introduce a query model based on log-likelihood weights for each of the Gent criteria to query the DB for mutations of related phenotypes. In the following the log-likelihood weights are defined as phenotype scores.
Phenotype score calculation
Let DB be a genotype-phenotype database organized in the form of a set of tuples
where c j is a specified mutation class and o is the set of clinical manifestations (0/1). The symbol 2 means ''belong to,'' && is ''and.'' It is important to note that mutation classes can be specified at different levels of mutational information: (i) at the level of mutation type (DNA level), e.g., a substitution, (ii) at the level of mutation type and consequence (DNA and protein level), e.g., substitution/missense, or (iii) at the level of mutation type and consequence, and location of mutational event(s) in the gene or the affected protein domain(s), e.g., substitution/missense/exons 3-5 or EGF domain. However, if enough tuples of an explicit mutation are available, a score set at this highest level of mutational information is generable. We propose at least 25 tuples per class/type of mutations to generate representative score sets. The entropy of a phenotype probability distribution P = (p 1 , . . . , p N ) is defined as
where p j is the frequency (probability) of a symptom within the class c j . H(P) is the entropy of the Gent phenotype with respect to (w.r.t.) a class c j in bit. N is the total number of considered symptoms. The relative entropy of two probability distributions P and Q is computed as
where p i is again the frequency of a symptom within class c j while q i is defined as the frequency of the symptom in DB, excluding all tuples of class c j . A score value s i of a single symptom w.r.t. class c j is thus given as
where k is a scaling factor (we set k = 100 A matrix M of score sets can be generated, where c j 2 C represent specified mutation classes at the same level of mutational information, e.g., Sub/Mis, Sub/ Stop, Del/Fs, Ins/Fs, etc:
where s is the set of score values of a clinical phenotype w.r.t. mutation class c j and S is the collectivity of score sets in M. The symbol R represents the set of all real numbers.
To assess phenotypic similarity/dissimilarity between a specified mutation class c j 2 M and a requested MFS phenotype we calculate the parameter s c , a measure for the information content of a given score set. It is defined:
The larger s c , the smaller the phenotypic similarity between a mutation class c j and the requested phenotype.
Similarity requests on specified mutation classes
To assign a query phenotype O = {o|(o 1 , . . . , o N ), o 2 (0,1)} of unknown mutation to a specified mutation class c j 2 M, we present a matching paradigm that operates on matrix M by processing similarity requests for each class c j 2 M. Two steps must be processed for this task:
1. Balancing of the score matrix M w.r.t. all specified mutation classes c 2 M. The absolute score values s c of classes c 2 M can significantly differ in size which can lead to a preferred assignment of the query tuple O to that class c j which is represented by the highest measure s c within M. Therefore, each score set s 2 S has to be corrected to the mean absolute score s c , which is calculated as the mean value of all s c 2 M, to balance matrix M. Therefore, M * is the s c -balanced matrix of M with s * 2 M * . 2. Assignment of the query phenotype O weighted by the balanced score sets s * 2 M * to a mutation class c j 2 M * . The decision rule is defined as follows:
Here, the query model built on a square distance measure assigns the MFS query phenotype O to that mutation class c j 2 M * , whose distance is maximal.
Similarity requests for explicit mutations on DB
For searching mutations of related phenotypic expression in DB, a similarity request at the level of explicit mutations can be processed if score sets of single mutations can be generated. We know from the clinical situation that more than 20-25 subjects per mutation are not available because of the multiplicity of mutations. We therefore propose at least 5-10 tuples per mutation for the scoring task. An explicit mutation m s , of which a score set s can be generated, can formally be written as
Let DB be a genotype-phenotype database at the level of single mutations given in the form of a set of tuples
where m j is an explicit mutation and o is the set of clinical manifestations. MU is the collectivity of all different mutations represented in DB. For a DB request the query model of mutation m s uses the following similarity measure:
Here, s 2 S represents the score set of mutation m s as defined in Eq. (8) (cf. Table 3 , M 5 ). The best ranked hits T according to maximal value of ŝ m are returned as the query result.
Data mining strategy
We propose a straightforward data mining procedure to support feature selection, classification, and cluster analysis suitable for correlating mutational and clinical information.
Feature selection and probabilistic models
Feature selection is an important task for genotypephenotype correlation aiming at the identification of clinical key manifestations (''diagnostic markers'') from the collection of given diagnostic criteria. In particular, classification accuracy of machine learning methods often degrades if the number of features in data is large resulting in many of them becoming irrelevant for classification [24, 25] .
For our framework we propose the so-called wrapper approach with logistic regression analysis (LRA) as the learning method [26] [27] [28] . This strategy enables us to identify key markers in one analytical run on which finally a classification model of minimized error rate is built. We used forward selection with a backtracking facility. Search termination, i.e., the amount of backtracking, was set to 5. LRA was chosen since class membership is assigned by a probability measure. This measure is of importance if prognostic and diagnostic questions in a clinical context arise. The probability for class membership is given as P (Y = 1) = 1/[1 + exp (Àz)], where z represents the logit of the model. Basically, LRA was designed for a two-class problem. For multiple hypotheses testing, the classification problem can be reduced to a two-class problem by testing all possible pair-wise combinations or by using a multinomial logistic regression approach.
For the train and validation cycle we used leave-one out cross validation of the overall data analysis process to avoid underestimation of error rates due to the small number of cases per class. Generally, train and test or stratified 10-fold cross validation is suggested if the datasets are larger. The modelsÕ classification accuracy was assessed by determining the established quality measures: accuracy, recall (TP rate), and precision [29] .
Cluster analysis
Hierarchical cluster analysis was applied to divide MFS phenotypes into meaningful subgroups. It permits the user to interactively change a given cluster hierarchy with visual feedback [30] . We used the complete linkage approach, i.e.,
to calculate the distances. No attribute-wise normalization was required because of the dichotomous character of phenotypic data (symptom present/absent), and Manhattan distance was chosen as the distance function. To determine a proper number of clusters, the linkage distance (scaled between 0 and 1) must be changed.
For assessment of cluster results we evaluated the proportions of the different mutation classes and determined the frequency of manifestations in each cluster. Additionally, we calculated the entropy H of each cluster according to Eq. (2) to estimate the homogeneity/inhomogeneity of manifestations in the cluster.
Results
Frequency and scoring matrices
Mutation classes were specified at different levels of mutational information. Scoring matrices were generated based on data subsets returned from DB queries utilizing the underlying data model. Table 2 summarizes the frequencies of investigated symptoms w.r.t. specified classes. Table 3 shows the corresponding score sets.
By way of example, three classes of mutations, i.e., Sub/Mis, Sub/Stop, and Del/Fs, could be specified at the level of type and consequence of mutations. Within these classes, ectopia lentis (EL) manifested in 82% of missense mutations (score 89), but only in 22% of nonsense mutations (score À35). Interestingly, in deletions causing FS + PTC we observed a similarly decreased frequency of EL of 35% (score = À31). Nonsense mutations showed the second highest proportion of aortic dilatation (AA-DIL = 81%, score = 18) and the highest risks for aortic dissection (AADIS = 22%, score = 30), and thus lead to the most severe phenotypic expressions in the CVS with high risk of life-threatening complications. The highest accumulated absolute score s c was also calculated for this mutation class (362), which emphasizes its low degree of phenotypic similarity w.r.t. DB. Explicit mutations, however, yielded the largest s c values (s 507del1 = 601, s 7801C>T = 621) arising from maximum homogeneity of several manifestations. Moreover, both mutations point out a close phenotypic similarity since phenotypic expressions are almost equal.
Assignment of MFS phenotypes to specified mutation classes
Four s c -balanced matrices, M
, were generated. For each matrix M * , similarity requests w.r.t. the specified mutation classes c 2 M * were performed by testing data of our research DB. Cases which could not be assigned to one of the classes c specified in M * prior to these experiments were excluded because they were undefined in M * . Classification accuracy of matching is summarized in Table 3 .
Similarity requests w.r.t. score matrix M Ã 1 lead to a recall rate of 67% (substitutions) vs. 59% (non-substitutions), with an overall classification accuracy of 65%. Despite the lowest level of mutational information, recall rates were remarkably high so that if all Gent criteria were considered we would even expect a higher accuracy. Three mutation classes (missense, nonsense mutations, and deletions causing FS + PTC) could be generated at the level of type and consequence ðM Ã 2 Þ. Eighty-two percent of Sub/Mis mutations and 61% of Del/Fs were correctly assigned, while the majority of nonsense mutations were wrongly classified to the Del/ Fs class. Comparing score sets of Sub/Stop and Del/ Fs, both groups yielded partly similar score values, which cause the incorrect assignment. Location and type of mutational events were considered for class specification in M Ã 3 and M Ã 4 . Recall values of 0.04% and 14.6%, respectively, demonstrated that one of both classes was wrongly assigned. Marginal differences between the phenotypic expressions emphasize this result.
Requests of explicit mutations on DB
Similarity requests of explicit mutations on DB are applicable if requested mutations can be characterized by a score set. We performed a request for the mutation 507del1;Y170TfsX20 of which a score set was generable (see Table 3 , M 5 ). The returned query result is shown in Table 4 .
The best 20 hits ($12% of DB) assessed by the similarity measure ŝ m are displayed. Eighty percent of them are Sub/Stop or Del/Fs mutations, one is a deletionsplice site mutation (Del-Splice/?), and 15% are Sub/ Mis mutations. No substitution-splice site mutations were returned. Among the first 10 hits solely Sub/Stop or Del/Fs mutations were displayed. The 507del1 mutation on which the query score set was generated was displayed four times. ? denotes data not available (length of frameshift, AA change or consequence at the protein level). 
Diagnostic markers and probabilistic models
We focused on the investigation of the Sub/Mis, Sub/ Stop, and Del/Fs mutation classes. Here, key manifestations could be identified on which LRA models of minimal classification error rates were built.
Superior classification accuracy was achieved when separating missense mutations from stop and/or deletions/FS + PTC mutations (both models 80%). Highest discriminatory performance yielded the Sub/Mis vs. Sub/Stop model (accuracy = 87%), however, with unbalanced recall rates of 92% (Sub/Mis) and 70% (Sub/Stop), respectively. Ectopia lentis (EL) represents the hallmark manifestation in all three classes. In addition to EL ascending aortic dilatation (AADIL) and one skeletal major symptom (WTS) distinguished between Sub/Mis and Sub/Stop mutations, ascending aortic dissection (AADIS) and several skeletal manifestations (PC, ASR, WTS, PE, and JH) distinguished between Sub/Mis and Del/Fs mutations, and thus were identified as the predominant diagnostic markers. Merging Sub/Stop and Del/Fs class, and testing it against the Sub/Mis class, EL, PC, ASR, PE, and HAP were the discriminatory markers. EL, AADIL and AADIS were the markers discriminating between Sub/Stop and Del/Fs mutations best. However, classification accuracy of the latter model was relatively low (64%, recall 87% and 37%). Mitral valve prolapse (MVP) and both skin minor criteria (HE, SA) never appeared in the selected subsets and do not seem to have diagnostic value when distinguishing between Sub/Mis, Sub/Stop, and Del/Fs mutations.
Cluster analysis
Hierarchical cluster analysis was performed on the set of clinical manifestations. Again, we focused on subjects carrying a Sub/Mis, Sub/Stop or Del/Fs mutation (Fig. 2) . Table 5 summarizes the evaluation of identified clusters.
Four meaningful clusters were generated at a linkage distance >0.2. Here, clusters c 1 -c 3 , merged at the linkage distance <0.2 were more closely related to each other than to the remaining cluster c 4 . Cluster c 4 differed significantly from c 1 to c 3 , showing the mildest phenotypic expressions. Here, 11 of 14 symptoms showed a frequency below 50%, nine indicated a frequency even below 25%. Ninety-two percent of this cluster consisted of missense mutations. The mean probability that P (Sub/ Mis = 1) ranged between 81 and 93%, however depended on the applied LRA model. The most severe phenotype was represented by cluster c 1 0 , one of four subclusters of c 1 split up at a linkage distance >0.45, and contained predominantly Sub/Stop and Del/Fs mutations (together 87% vs. 13% Sub/Mis). In parallel, the mean probability P (Sub/Mis = 1) decreased to 61-78% Table 5 Evaluation of identified clusters using hierarchical cluster analysis is split up at a linkage distance >0.45 (Fig. 2 ).
in this sub-cluster. Interestingly, the entropy H for subcluster c 1 0 achieved the lowest value (2.57 bit vs. 5.24 bit for c 4 ) which can be explained by maximal class homogeneity of five symptoms (AADIL, MVP, WTS, HAP, and SA > 95%) and additionally the absence of three manifestations (AADIS, PES, and HE). Thus, cluster c 1 0 is closely correlated with Sub/Stop and Del/Fs mutations, and c 4 with Sub/Mis mutations.
Discussion
Genotype-phenotype correlation in humans with FBN1 gene mutations is a challenging bioinformatics task. In particular, the age-related and pleiotropic nature of the MFS as well as its intra-and inter-familial heterogeneity seem to make this task unmanageable [10, 17, 19] . The lack of a publicly available FBN1 resource providing a maximum degree of genetic and phenotypic information, and the absence of an informatics framework for data management, analysis, and representation are mainly responsible for the moderate progress of defining genotype-phenotype correlation.
Indeed, the two public FBN1 mutation DBs, HGMD (Human gene mutation database, http://archive.uwcm. ac.uk/uwcm/mg/search/127115.html) and UMD (Universal mutation database, www.umd.be:2030/gene.html and www.umd.necker.fr), are not sufficient to systematically link genetic and clinical information; while HGMD focuses on the collection, description, and literature annotation of published FBN1 mutations, UMD includes some more phenotypic information. UMD is currently the only publicly available FBN1 genotype-phenotype database that provides data at DNA, protein, and clinical levels similar to our resource [4] . The clinical information, however, contains merely the involvement (+/À) of the affected organ systems, and therefore UMD is useless for extended genotype-phenotype investigations.
In this article, we propose a bioinformatics framework for FBN1 genotype-phenotype correlation, which will be publicly available via a web portal. A central component of the information system is a relational DBMS for storing and managing mutation data, clinical data according to the Gent nosology and, in future, additional aortic elastic parameters to better monitor aortic abnormality [9, 10] . The underlying database scheme represents a biological model of a multi-systemic inherited disease, which describes mutations and their polymorphisms in DNA and protein sequences, and the diseaseÕs variability in phenotypic expression comprehensively. Thus, our methodology is well generalizable to other monogenic diseases causing phenotypic pleiotropy; only an adaptation of the phenotype data model is needed. Depending on the amount of mutations, the number of involved organ systems and diagnostic key features, and the number of required cases to perform genotype-phenotype correlations vary. If data analysis is performed at mutation type and consequence (cDNA and protein) level, a number of cases comparable to our study is essential. Considerably more data are required, if data are analyzed at the level of location of mutational events in the gene or the affected protein domains, so that the web portal will help to collect sufficient data worldwide to perform genotype-phenotype investigations at this level in future.
For advanced DB requests the proposed data model permits queries for the wide spectrum of mutation types, subtypes and their mutational events which are required for the generation of the score sets at different levels. We introduced log-likelihood weights as similarity measures to match phenotypes, similar to the well-known PAM or BLOSUM matrices, which were developed for protein sequence alignment. Thus this simple retrieval technique permits the search of mutations of related phenotypes on DB, as exemplified for 507del1;Y170TfsX20, which may be helpful, e.g., to estimate the degree of intraand inter-familial heterogeneity of the syndrome.
Relevant diagnostic markers were identified using a wrapper-based feature selection approach. This strategy is preferred to the filter method, since computational limitations caused by the size of DB (>600 published FBN1 mutations) and the dimensionality of investigated data (n < 30) may not arise [26, 27] . In particular, LRA models fulfill the requirement of clinical experts to have a quantitative (probability), not only a qualitative measure for patient classification. Hierarchical cluster analysis was proposed for sub-grouping phenotype data. Due to the high variability within the MFS phenotype, mutation classes of enhanced phenotypic homogeneity are surprising (cf. c 1 0 and c 4 ), since clusters with high class homogeneity are indicators for a very close genotype-phenotype relationship. The proposed data mining strategy, which takes both a supervised and non-supervised view of data analysis into account, properly addresses prognostic and diagnostic questions for the correlation task. Nevertheless, the evaluation and further development of data mining procedures are in progress, so that in the future new meaningful approaches can readily be incorporated in the framework.
A few accepted genotype-phenotype correlations in the MFS have been reported, e.g., with a hot spot for neonatal MFS in exons 24-32 or a clustering of mutations causing milder forms in exons 59-65. More common occurrence of large-joint hypermobility (JH), less common ectopia lentis (EL), and retinal detachment are associated with premature termination codon (PTC) mutations, while, e.g., missense mutations show a high frequency of EL [1, [13] [14] [15] [16] [17] 31] . Using the proposed bioinformatics framework, some of the aforementioned correlations could be confirmed. A few novel ones were identified, although some limitations concerning the incomplete description of symptoms in the literature and the limited size of our current research DB exist. Maximum phenotypic dissimilarity was found between missense mutations and the groups of nonsense mutations and deletions causing FS + PTC. The latter both classes indicate similar phenotypic expressions (cf. Tables 2 and 3). This can be explained by related mutational events causing termination of fibrillin-1 synthesis. Key manifestations, which are relevant for best discriminating between Sub/Mis and Sub/Stop + Del/Fs classes, are EL and several skeletal (major and minor) criteria, but not manifestations of the CVS and the skin system. Comparing missense and nonsense mutations-independent of the location of the mutational event-AADIS appears to be an additional key marker predominantly observed in patients carrying a nonsense mutation. More severe manifestations in the CVS lead to a higher risk of life-threatening aortic dissection or rupture which require immediate therapeutic intervention. The most severe phenotypic expressions were solely found in patients carrying a Sub/Stop or Del/Fs mutation, while the mildest MFS phenotype appeared in Sub/Mis mutations. No difference was found if, e.g., point mutations at different gene locations (exons 1-24 vs. exons 25-68) or with different mutational events (transitions vs. transversions) were compared.
In summary, our proposed bioinformatics framework for FBN1 genotype-phenotype correlation provides a pipeline for data management and analysis which can help to better link genetic and clinical information. Using this framework some well-known genotype-phenotype correlations could be confirmed and other novel correlations were identified, which emphasize the power of the methodology to address these important questions with respect to diagnosis and therapy of MFS.
